Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Cytek Biosciences, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Laboratory Analytical Instruments
Prev close 4.87 · gapped above the open, then crossed back over prior close. High/low 5.00 at 9:45 am ET, 4.86 at 3:30 pm ET.
CTKB (Cytek Biosciences, Inc.) has 5 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: BDX +1.56%, in healthcare.
153 institutional managers report a position in Cytek Biosciences, Inc. worth $361.1M between them, filed on form 13F for the quarter ending 2026-06-30. 18 of them hold 80% of it, the largest being BlackRock, Inc. at 11.75%.
128 more managers in the register
18 managers hold 80% of the $361.1M institutional base. The other 135 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Topline Capital Management, LLC, Arrowstreet Capital, Limited Partnership, Tudor Investment Corp ET AL +6 more · 7.71% of CTKB, 10.78% of PRAA
via Boston Partners, Royce & Associates LP, Acadian Asset Management LLC +1 more · 9.40% of CTKB, 9.59% of TBI
via Boston Partners, Acadian Asset Management LLC, Marshall Wace LLP +2 more · 9.40% of CTKB, 14.17% of AII
via Boston Partners, Royce & Associates LP, Arrowstreet Capital, Limited Partnership +4 more · 9.40% of CTKB, 5.99% of NOMD
via Boston Partners, Arrowstreet Capital, Limited Partnership, Qube Research & Technologies Ltd +1 more · 9.40% of CTKB, 9.56% of HLLY
via Hillhouse Capital Advisors, Ltd., Acadian Asset Management LLC, Arrowstreet Capital, Limited Partnership +1 more · 8.17% of CTKB, 8.41% of API
Managers holding a meaningful stake in CTKB also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.